Gauzy
PublicGauzy is now publicly traded
The data on this page reflects Gauzy's private-market history up to the point it went public, including its funding rounds, valuation, and investors.
Went Public
Jun 6, 2024
Last Round
Early Funding
Dec 2, 2025
Total Funding Raised
$211.9M
Company Overview
Gauzy operates in Technology and is based in Tel Aviv. Its recorded funding history includes a Convertible Debt round in March 2023.
Gauzy (NAS: GAUZ) is a technology company specializing in integrated light and vision control solutions, offering products such as suspended particle devices, liquid crystal films for smart glass applications, and advanced driver assistance systems for various vehicles and aircraft.
Sector
Technology
AI Layer
Non-AI
Gauzy Comparables
Compare Gauzy with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ambilight Inc. | 80% | |
| Furcifer Inc. | 72% | |
| Halio, Inc. | 71% |
For institutional investors. Book with your work email.
Gauzy Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Dec 2, 2025 | ||||
| Debt | Aug 8, 2024 | ||||
| IPO | Jun 6, 2024 | ||||
| Convertible Debt | Mar 31, 2023 | ||||
| Series D | Feb 8, 2022 | ||||
Series C | Apr 23, 2020 |
For institutional investors. Book with your work email.
Gauzy Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Waarde Capital | Series B, Series D |
| Hyundai CRADLE | Series C |
| OTV | Series B |
| Ibex Investors | IPO, Series B, Series D |
| BlueRed Partners | Series C |
| Walleye Capital | Convertible Debt, Series D |
| Orion Infrastructure Capital | Early Funding |
For institutional investors. Book with your work email.
Gauzy Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.